[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367781-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367781-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","prevalence-of-precancerous-cervical-lesion-and-its-associated-factors-among-hivaids-positive-and-negative-women-a-cross-sectional-study","Prevalence of Precancerous Cervical Lesion and Its Associated Factors Among HIV/AIDS Positive and Negative Women in Debre Berhan Comprehensive Specialized Hospital, North Shewa Zone, Amhara Regional State, Ethiopia - A Cross-Sectional Study","","Pre-invasive cervical lesions typically advance over a long period before progressing to cervical cancer, making early screening and treatment at the pre-invasive stage crucial for reducing morbidity and mortality. This institutional-based comparative cross-sectional study assessed the prevalence and determinants of precancerous cervical lesions among HIV-positive and HIV-negative women attending screening in Debre Berhan Comprehensive Specialized Hospital from July 2021 to June 2023.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prevalence-of-precancerous-cervical-lesion-and-its-associated-factors-among-hivaids-positive-and-negative-women-a-cross-sectional-study/367781/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prevalence-of-precancerous-cervical-lesion-and-its-associated-factors-among-hivaids-positive-and-negative-women-a-cross-sectional-study/367781.png","ImageObject",300,407,{"name":42,"@type":43},"Mimi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s objective?","Question",{"text":63,"@type":64},"To assess the prevalence and associated factors of precancerous cervical lesions among HIV-positive and HIV-negative women attending a specific hospital in Ethiopia.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the study conducted?",{"text":68,"@type":64},"An institutional-based comparative cross-sectional design was used from July 2021 to June 2023 among women attending cervical cancer screening, with records extracted using a structured checklist.",{"name":70,"@type":61,"acceptedAnswer":71},"What prevalence of precancerous cervical lesions did the study report?",{"text":72,"@type":64},"The overall prevalence was reported as 8%, with different prevalence estimates for HIV-positive versus HIV-negative women.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367781,1790201684,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Health Science Reports  \nORIGINAL RESEARCH   \nPrevalence of Precancerous Cervical Lesion and Its Associated Factors Among HIV/AIDS Positive and Negative Women in Debre Berhan Comprehensive Specialized Hospital, North Shewa Zone, Amhara Regional State, Ethiopia: A Cross‐Sectional Study  \nEsubalew Tesfahun1  | Demsash Eshete1 | Zenebe Abebe1 | Solomon Hailemeskel2  \n1School of Public Health, Asrat Woldeyes Health Science Campus, Debre Berhan University, Debre Berhan, Ethiopia | 2School of Nursing and Midwifery,  \nAsrat Woldeyes Health Science Campus, Debre Berhan University, Debre Berhan, Ethiopia Correspondence: Esubalew Tesfahun ([esubalew.tesfahun@gmail.com](esubalew.tesfahun@gmail.com))  \nReceived: 14 October 2024 | Revised: 15 July 2025 | Accepted: 30 July 2025  \nKeywords: HIV‐positive and negative | human papillomavirus | precancerous cervical lesion | prevalence  \nABSTRACT  \nBackground: Pre‐invasive cervical lesion typically progresses for a considerable amount of time before developing into cervical cancer (CC) . Consequently, early detection and treatment of cervical cancer at the pre‐invasive stage may be advantageous to the patients and lessen the burden of morbidity and mortality from the disease. Our country has limited studies on Precancerous Cervical Lesions (PCCL) .  \nAims: To assess the prevalence and associated factors of precancerous cervical lesions among HIV‐positive and negative women in Debre Birhan Comprehensive Specialized Hospital, Ethiopia.  \nMethods: An institutional‐based comparative cross‐sectional study was conducted from July/2021 to June/2023 among 522 women attending cervical cancer screening at Debre Birhan Comprehensive Specialized Hospital. All records during the study period were collected using a structured data extraction checklist. Binary logistic regression analyses were conducted to identify factors associated with pre‐cancerous cervical lesions.  \nResults: The overall prevalence of pre‐cancerous cervical lesions was 8%(95% CI: 5.6–10.5 . The prevalence of pre‐cancerous cervical lesions in HIV‐positive was 5.4%(95% CI: 2.8–.1) and in HIV‐negative women 10.7%(95% CI: 5.6–8.1) . Women with lifetime sexual partner ≥ 2 (AOR = 3.84, 95% CI: 1.06–3.97), who have a history of STI (AOR = 5.66, 95% CI: 1.50–21.41) and women with age ≥ 45 years (AOR = 4.22, 95% CI: 1.21–14.76) were contributing factors of a PCCL for HIV‐positive women. In addition, women with a history of Sexually Transmitted Infection (STI) (AOR = 6.51, 95% CI: 2.11–0.09) and who have a lifetime sexual partner ≥ 2 (AOR = 8.4, 95% CI: 2.85–4.79) were statistically significant association with pre‐cancerous cervical lesion for HIV‐negative women.  \nConclusion: The overall prevalence of pre‐cancerous cervical lesions was found to be low in this study relative to the national prevalence. However, strengthening routine screening of women for pre‐cancerous cervical lesions and behavioural change communication on risk factors is very important.  \nThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.  \n© 2025 The Author(s) . Health Science Reports published by Wiley Periodicals LLC.  \nHealth Science Reports, 2025; 8:e71178 1 of 9  \n[https://doi.org/10.1002/hsr2.71178](https://doi.org/10.1002/hsr2.71178)  \n1 | Introduction  \nCervical cancer (CC) typically develops after a prolonged phase of pre‐invasive lesions in the cervix, where abnormal cervical cells start to grow uncontrollably, eventually forming a tumour [1] . Sexually transmitted HPV types fall into two groups: low‐ risk and high‐risk. High‐risk HPVs can cause several types of cancer. Low‐risk HPV types rarely cause cancer, although a few low‐risk HPV types can cause warts on or around the genitals, anus, mouth, or throat. In the transformation zone of t","cbCaiijsYdQdUfpK","https://ap.wps.com/l/cbCaiijsYdQdUfpK","pdf",460607,"English","# Abstract\n## Background\n## Aims\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the study’s objective?\",\"answer\":\"To assess the prevalence and associated factors of precancerous cervical lesions among HIV-positive and HIV-negative women attending a specific hospital in Ethiopia.\"},{\"question\":\"How was the study conducted?\",\"answer\":\"An institutional-based comparative cross-sectional design was used from July 2021 to June 2023 among women attending cervical cancer screening, with records extracted using a structured checklist.\"},{\"question\":\"What prevalence of precancerous cervical lesions did the study report?\",\"answer\":\"The overall prevalence was reported as 8%, with different prevalence estimates for HIV-positive versus HIV-negative women.\"}]","Prevalence of Precancerous Cervical Lesion and Its Associated Factors Among HIV/AIDS Positive and Negative Women in Debre Berhan Comprehensive Specialized Hospital, North Shewa Zone, Amhara Regional State, Ethiopia - A Cross-Sectional Study | PDF",1790172585,23,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5214307ea60cd003e492f519ed1bd564.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8106761db4d00ce0ffd38ccb015fe50f.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c86698e8ee7ccbef2737107bf8cfa6ab.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3877b7f32f358395429e6e474cf11e7a.webp",980,1287]